Tag: Multiple Sclerosis
Various Clinical Disturbances Precede MS Diagnosis
Understanding prodromal signs may improve multiple sclerosis identification
FDA Expands Use of MS Drug to Include Children
Gilenya is the first multiple sclerosis drug approved for children
Guidelines Developed for Use of Drugs in Multiple Sclerosis
Guidelines relate to starting, switching, stopping disease-modifying therapies
Siponimod Cuts Risk of Disability Progression in Multiple Sclerosis
Reduction in 3-month confirmed disability progression in secondary progressive multiple sclerosis
Higher Sun Exposure Tied to Lower Risk of Multiple Sclerosis
Findings based on sun exposure at 5 to 15 years of age and at 5 to 15 years before MS onset
AAN: High Fish Intake Linked to Reduced Risk of Multiple Sclerosis
Two tag SNPs in fatty acid desaturase gene 2 independently linked to reduced risk of MS
Rituximab Tops Other Disease-Modifying Tx Options in MS
Better efficacy, lower discontinuation rate in newly diagnosed relapsing-remitting multiple sclerosis
Diet Quality Linked to Disability, Symptom Severity in MS
Composite healthy lifestyle linked to lower odds of fatigue, depression, pain, cognitive impairment
Percutaneous Transluminal Angioplasty Ineffective in MS
Findings in patients with relapsing-remitting MS and chronic cerebrospinal venous insufficiency
MRN Helps Quantify Peripheral Nerve Involvement in MS
High-resolution magnetic resonance neurography detected lesions in all multiple sclerosis patients examined
